WO2002015841A3 - Medicine for treating female sexual dysfunction by acting on the central nervous system - Google Patents

Medicine for treating female sexual dysfunction by acting on the central nervous system Download PDF

Info

Publication number
WO2002015841A3
WO2002015841A3 PCT/FR2001/002624 FR0102624W WO0215841A3 WO 2002015841 A3 WO2002015841 A3 WO 2002015841A3 FR 0102624 W FR0102624 W FR 0102624W WO 0215841 A3 WO0215841 A3 WO 0215841A3
Authority
WO
WIPO (PCT)
Prior art keywords
medicine
acting
sexual dysfunction
nervous system
female sexual
Prior art date
Application number
PCT/FR2001/002624
Other languages
French (fr)
Other versions
WO2002015841A2 (en
Inventor
Francois Giuliano
Kenna Kevin Mac
Original Assignee
Pelvipharm Sa
Francois Giuliano
Kenna Kevin Mac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelvipharm Sa, Francois Giuliano, Kenna Kevin Mac filed Critical Pelvipharm Sa
Priority to AU2001284145A priority Critical patent/AU2001284145A1/en
Priority to EP01963104A priority patent/EP1377344A2/en
Publication of WO2002015841A2 publication Critical patent/WO2002015841A2/en
Publication of WO2002015841A3 publication Critical patent/WO2002015841A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns the use of selegiline and its pharmaceutically acceptable salts to obtain a medicine for treating female sexual dysfunction by increasing libido, sexual arousal and excitability.
PCT/FR2001/002624 2000-08-25 2001-08-17 Medicine for treating female sexual dysfunction by acting on the central nervous system WO2002015841A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001284145A AU2001284145A1 (en) 2000-08-25 2001-08-17 Medicine for treating female sexual dysfunction by acting on the central nervous system
EP01963104A EP1377344A2 (en) 2000-08-25 2001-08-17 Medicine for treating female sexual dysfunction by acting on the central nervous system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR00/10966 2000-08-25
FR0010966A FR2813193B1 (en) 2000-08-25 2000-08-25 MEDICINE FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS BY ACTION ON THE CENTRAL NERVOUS SYSTEM

Publications (2)

Publication Number Publication Date
WO2002015841A2 WO2002015841A2 (en) 2002-02-28
WO2002015841A3 true WO2002015841A3 (en) 2003-10-09

Family

ID=8853750

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/002624 WO2002015841A2 (en) 2000-08-25 2001-08-17 Medicine for treating female sexual dysfunction by acting on the central nervous system

Country Status (4)

Country Link
EP (1) EP1377344A2 (en)
AU (1) AU2001284145A1 (en)
FR (1) FR2813193B1 (en)
WO (1) WO2002015841A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985889A (en) * 1994-04-22 1999-11-16 Pentech Pharmaceuticals, Inc. Dosage forms and method for ameliorating male erectile dysfunction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985889A (en) * 1994-04-22 1999-11-16 Pentech Pharmaceuticals, Inc. Dosage forms and method for ameliorating male erectile dysfunction

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
ACTA PHYSIOLOGICA HUNGARICA. HUNGARY 1996, vol. 84, no. 3, 1996, pages 277 - 278, ISSN: 0231-424X *
BENET ET AL: "The Medical Treatment of erectile Dysfunction", DRUGS OF TODAY / MEDICAMENTOS DE ACTUALIDAD,ES,J.R. PROUS SS.A. INTERNATIONAL PUBLISHERS, vol. 32, no. 6, 1 September 1996 (1996-09-01), pages 483 - 499, XP002095494, ISSN: 0025-7656 *
DALLO J ET AL: "AGE DEPENDENT DECREASE OF COPULATORY ACTIVITY AND ITS CORRECTION BY(-)DEPRENYL IN MALE RATS", ADVANCES IN PHARMACOLOGICAL RESEARCH AND PRACTICE,XX,XX, vol. 3, 1985, pages 35 - 38, XP000575182 *
DALLO J ET AL: "Effect of levo-deprenyl on sexual activity and lifespan in female rats.", ACTA BIOCHIMICA ET BIOPHYSICA HUNGARICA, vol. 26, no. 1-4, 1991, Annual Meeting of the Neuroscience Section of the Hungarian Physiological Society;Visegrad, Hungary; January 23-25, 1992, pages 153, XP009003691, ISSN: 0237-6261 *
DALLO J ET AL: "THE EJACULATORY BEHAVIOR OF SEXUALLY SLUGGISH MALE RATS TREATED WITH (-)DEPRENYL, APOMORPHINE, BROMOCRIPTINE AND AMPHETAMINE", POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY,POLISH ACADEMY OF SCIENCES INSTITUTE OF,PL, vol. 38, no. 3, 1986, pages 251 - 255, XP000972480, ISSN: 0301-0244 *
DALLO J: "Effect of longevity treatment with (-)deprenyl on lifespan and sexual behavior in female rats.", NEUROBIOLOGY (BUDAPEST), vol. 9, no. 1, 2001, pages 33 - 35, XP009003679, ISSN: 1216-8068 *
DATABASE MEDLINE [online] 1996, DALLÓ J ET AL: "Longevity treatment with (-)deprenyl in female rats: effect on copulatory activity and lifespan.", XP002226834, Database accession no. NLM9219605 *
FERRARI F ET AL: "INABILITY OF (-)DEPRENYL TO MODIFY COPULATORY PERFORMANCE IN THE MALE RAT, WHETHER OR NOT STIMULATED BY THE SELECTIVE D2 DOPAMINE AGONIST SND 919", PHARMACOLOGICAL RESEARCH,GB,ACADEMIC PRESS, LONDON, vol. 29, no. 4, 1994, pages 373 - 382, XP000866497, ISSN: 1043-6618 *
KNOLL J ET AL: "LONG-LASTING, TRUE APHRODISIAC EFFECT OF (-)-DEPRENYL IN SEXUALLY SLUGGISH OLD MALE RATS", MODERN PROBLEMS OF PHARMACOPSYCHIATRY,CH,KERGER, BASEL, vol. 19, 1983, pages 135 - 153, XP000575123, ISSN: 0077-0094 *
KNOLL J ET AL: "STRIATAL DOPAMINE, SEXUAL ACTIVITY AND LIFESPAN. LONGEVITY OF RATS TREATED WITH (-) DEPRENYL", LIFE SCIENCES,GB,PERGAMON PRESS, OXFORD, vol. 45, no. 6, 1989, pages 525 - 531, XP000575063, ISSN: 0024-3205 *
MORALES A: "NONSURGICAL MANAGEMENT OPTIONS IN IMPOTENCE", HOSPITAL PRACTICE,US,NEW YORK, NY, vol. 28, no. 3A, 30 March 1993 (1993-03-30), pages 15 - 16,19-20,23-2, XP000645172 *

Also Published As

Publication number Publication date
EP1377344A2 (en) 2004-01-07
FR2813193A1 (en) 2002-03-01
FR2813193B1 (en) 2003-08-15
AU2001284145A1 (en) 2002-03-04
WO2002015841A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
BR0316753A (en) Treatment method for sexual dysfunction
YU30004A (en) Use of flibanserin in the treatment of sexual disorders
HN1999000015A (en) TREATMENT FOR A FEMALE SEXUAL DYSFUNCTION
BE2012C040I2 (en)
BG109297A (en) 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
BG105664A (en) Use of apomophines for the treatment of organic erectile dysfunction in males
WO2001098279A3 (en) Bis-arylsulfones
EP1440689A3 (en) Treatment of neurotic disorders
MY133446A (en) Treatment of impotence due to spinal cord injury
WO2005007149A8 (en) Ambroxol for treating acute pains
DOP2002000356A (en) CONJUGADOS DE PREGABALINA LACTOSA
WO2002015841A3 (en) Medicine for treating female sexual dysfunction by acting on the central nervous system
WO2001089557A3 (en) Methods for preventing strokes by inducing tolerance to e-selectin
WO2003000269A3 (en) Novel use for pde 10a inhibitors
PT1183046E (en) AMINOTETRALIN DERIVATIVES FOR THE THERAPY OF CARDIOVASCULAR DISEASES
MXPA03010919A (en) Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain.
MXPA03010920A (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia.
ZA200006374B (en) Compound for the treatment of female sexual dysfunction.
AU2002219246A1 (en) Methof for treatment of female sexual dysfunction

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001963104

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001963104

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001963104

Country of ref document: EP